News

New treatment approach shows potential in reversing lung damage caused by idiopathic pulmonary fibrosis using immune-based ...
Researchers at Tulane University have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a deadly ...
People with diseases caused by rare mutations have fewer options and poorer prospects than other patients despite rapid ...
Tulane scientists found that an FDA-approved cancer drug may help the immune system clear out damaged cells that cause lung ...
Adam Ball, who lives with cystic fibrosis which affects his ability to breathe, will swim the length of 13 lakes in the Lake ...
Researchers have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a deadly and currently incurable lung disease that affects more than 3 million people worldwide.
Have you ever heard of idiopathic pulmonary fibrosis (IPF)? Better yet, can you pronounce idiopathic pulmonary fibrosis?
An FDA-approved cancer drug that blocks the CTLA4 protein enabled immune cells to clear senescent cells in a mouse model of idiopathic pulmonary fibrosis (IPF), resulting in reduced lung scarring ...
Brensocatib significantly reduced the rate of pulmonary exacerbations and slowed lung function decline in patients with ...
This is part two of a two-part Healio Exclusive series on nutrition and lung health. Part one can be viewed here. Diet is an ...
Ann Sidesinger could barely walk 10 feet. Idiopathic pulmonary fibrosis had made her lungs thick and stiff. Even with an ...